Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.
PLoS One. 2020 Nov 10;15(11):e0242012. doi: 10.1371/journal.pone.0242012. eCollection 2020.
Co-infection with malaria and intestinal parasites is common in children in Africa and may affect their immune response to a malaria parasite infection. Prior studies suggest that co-infections may lead to increased susceptibility to malaria infection and disease severity; however, other studies have shown the reverse. Knowledge on how co-morbidities specifically affect the immune response to malaria antigens is limited. Therefore, this study sought to determine the prevalence of co-infection of malaria and intestinal parasites and its association with antibody levels to malaria merozoite antigens.
A cross sectional study was carried out in two villages with high transmission of malaria in Cameroon (Ngali II and Mfou) where mass drug administration (MDA) had been administered at ~6-month intervals (generally with albendazole or mebendazole). Children aged 1-15 years were enrolled after obtaining parental consent. A malaria rapid diagnostic test was used on site. Four (4) ml of peripheral blood was collected from each participant to determine Plasmodium falciparum infections by microscopy, haemoglobin levels and serology. Fresh stool samples were collected and examined by wet mount, Kato-Katz method and modified Ritchie concentration techniques. A Multiplex Analyte Platform assay was used to measure antibody levels.
A total of 320 children were enrolled. The prevalence of malaria by blood smear was 76.3% (244/320) and prevalence of malaria and intestinal parasites was 16.9% (54/320). Malaria prevalence was highest in young children; whereas, intestinal parasites (IP+) were not present until after 3 years of age. All children positive for malaria had antibodies to MSP142, MSP2, MSP3 and EBA175. No difference in antibody levels in children with malaria-co infections compared to malaria alone were found, except for antibody levels to EBA-175 were higher in children co-infected with intestinal protozoa (p = 0.018), especially those with Entamoeba histolytica infections (p = 0.0026).
Antibody levels to EBA175 were significantly higher in children co-infected with malaria and E. histolytica compared to children infected with malaria alone. It is important to further investigate why and how the presence of these protozoans might modulate the immune response to malaria antigens.
在非洲,疟疾和肠道寄生虫的合并感染在儿童中很常见,这可能会影响他们对疟原虫感染的免疫反应。先前的研究表明,合并感染可能导致对疟疾感染和疾病严重程度的易感性增加;然而,其他研究表明情况恰恰相反。关于合并症如何具体影响对疟原虫抗原的免疫反应的知识有限。因此,本研究旨在确定疟疾和肠道寄生虫合并感染的流行率及其与疟原虫裂殖体抗原抗体水平的关系。
在喀麦隆两个疟疾传播率较高的村庄(Ngali II 和 Mfou)进行了一项横断面研究,那里每 6 个月(通常使用阿苯达唑或甲苯达唑)进行一次大规模药物治疗 (MDA)。在获得家长同意后,招募了 1-15 岁的儿童。现场使用疟疾快速诊断测试。从每个参与者采集 4ml 外周血,通过显微镜检查、血红蛋白水平和血清学来确定恶性疟原虫感染。采集新鲜粪便样本,通过湿片法、加藤厚涂片法和改良瑞氏浓缩技术进行检查。使用多重分析物平台检测法来测量抗体水平。
共纳入 320 名儿童。血涂片检测的疟疾患病率为 76.3%(244/320),疟疾和肠道寄生虫的患病率为 16.9%(54/320)。年幼的儿童疟疾患病率最高;而肠道寄生虫(IP+)在 3 岁以后才出现。所有疟原虫阳性的儿童均有抗 MSP142、MSP2、MSP3 和 EBA175 的抗体。与单独患有疟疾的儿童相比,患有疟疾合并感染的儿童的抗体水平没有差异,除了合并感染肠道原生动物的儿童的 EBA-175 抗体水平较高(p=0.018),特别是感染溶组织内阿米巴的儿童(p=0.0026)。
与单独感染疟疾的儿童相比,感染疟疾和溶组织内阿米巴的儿童的 EBA175 抗体水平显著升高。需要进一步研究为什么以及如何这些原生动物的存在可能会调节对疟原虫抗原的免疫反应。